Method for obtaining testis leading tape mesenchymal stem cells from mouse testis leading tape culture
By isolating and purifying cells from mouse testicular lead-in tissues, a high-purity, multi-directional differentiation potential testicular lead-in mesenchymal stem cell bank was established, and the problems of low cell culture efficiency and unutilized functions in the existing technology were solved, and high efficiency was achieved Support for cell preparation and cryptorchidism studies.
Patent Information
- Application Number
- CN202411273988.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to efficiently culture and purify mouse testicular lead-in mesenchymal stem cells, and their multidirectional differentiation potential and reproductive regulatory functions are not fully utilized, limiting the progress of the etiology of cryptorchidism.
By isolating, digesting, and enriching cells from the testicular lead-in tissue of newborn mice, and purifying and passaged cells with collagenase and trypsin, a high-purity, multidirectional differentiation potential testicular lead-in mesenchymal stem cell bank is established, which is in line with the Standards of the International Society for Cell Therapy.
It has achieved high yield, high purity and rapid growth of testicular lead-up mesenchymal stem cells, possesses multi-directional differentiation potential and reproductive regulation functions, and is suitable for cryptorchidism research and treatment.
Smart Images

Figure CN119082008A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of stem cell culture, and particularly relates to a method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis culture. Background Art
[0002] Cryptorchidism is the most common congenital anomaly in newborns, with a reported incidence of 2%-4%. Until recently, the molecular etiology of this syndrome was unclear. Cryptorchidism may be part of a broader syndrome of testicular dysgenesis, a known risk factor for infertility and testicular cancer, thus necessitating surgical intervention.
[0003] The development of the gubernaculum testis (GT) plays a vital role in the testicular descent process. The gubernaculum testis is divided into the gubernaculum bulb and the gubernaculum cord. During the testicular descent, the gubernaculum bulb and the gubernaculum cord undergo a process of enlargement and extension. Since the gubernaculum bulb is relatively close to the internal ring of the inguinal canal, it pulls the testis and epididymis into the inguinal canal. At the same time, the massive swelling of the gubernaculum interstitial helps to expand the inguinal canal, which is a prerequisite for the subsequent passage of the testis through the inguinal canal. Studies have shown that part of the rat cremaster muscle is formed by the differentiation of peripheral mesenchymal cells of the gubernaculum bulb. These mesenchymal cells express immature myogenic proteins, which enable them to contract rhythmically and guide the testicles to descend to the scrotum.
[0004] It is still unclear what drives the morphological changes of the gubernaculum testis, which is similar to the embryonic development. Studies have shown that the front end of the gubernaculum testis of newborn rats can express myogenic stem cell markers, suggesting that a certain type of cells in the gubernaculum testis tissue has multipotency and can differentiate into muscle cells. At present, there is no related research on extracting gubernaculum testis tissue for in vitro cell culture.
[0005] Mesenchymal stem cells (MSCs) are a heterogeneous subpopulation of stromal stem cells that can be isolated from many adult tissues. They can differentiate into cells of the mesodermal lineage, such as adipocytes, osteocytes, and chondrocytes, as well as cells of other embryonic lineages. Their relative ease of isolation, combined with their ability to self-renew and multipotency, make MSCs a promising therapeutic option for a variety of clinical diseases. MSCs can interact with cells of the innate and adaptive immune systems, thereby regulating several effector functions.
[0006] At present, rats are mostly used for culturing gubernaculum mesenchymal cells due to the specificity of gubernaculum tissue and operational technical barriers. Compared with rats, mice are easy to raise, have a short gestation period, and have stable embryos, making it easier to extract gubernaculum tissue from newborn mice. In the process of screening rat gubernaculum cells using in vitro culture methods, multiple cells are mixed and difficult to purify and amplify in large quantities. Mouse gubernaculum tissue is small in size and not tightly adhered to the abdominal wall, making it easier to screen and purify. In addition, the multidirectional differentiation potential, high proliferation ability, and hormone regulation function of gubernaculum mesenchymal cells have never been confirmed, which provides new ideas for the study of the etiology of cryptorchidism and opens up new directions for stem cell therapy of the disease and the development of related drugs. Summary of the invention
[0007] In view of the shortcomings of existing technologies, this project provides a method for obtaining mesenchymal stem cells from mouse gubernaculum testis. The mesenchymal stem cells are cultured with high yield and purity using mouse gubernaculum tissue. The obtained cells have MSCs phenotype and multidirectional differentiation potential, which meets the standards of the International Society for Cellular Therapy (ISCT). Moreover, its genomics expresses more myogenic differentiation-related genes than MSCs from other sources such as umbilical cord, which is more conducive to the study of the cause of cryptorchidism and genomics research.
[0008] The object of the present invention is to provide a method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis tissue culture, comprising the following steps:
[0009] S1. Isolate the gubernaculum tissue from newborn male mice aged 0-3 days and clean the gubernaculum tissue;
[0010] S2. Add 1 mg / mL type I collagenase to the girdle tissue for digestion and dispersion, transfer to a culture bottle, add culture medium for static primary culture, and replace the culture medium when the primary culture reaches cell attachment;
[0011] S3. When the fusion rate of adherent cells reaches 80%, the cell colonies are digested with trypsin in a dot-like manner and then subcultured. After subculture to the third generation, a cell bank is established to obtain gubernaculum testis mesenchymal stem cells.
[0012] Preferably, the step S1 of cleaning the leader tissue comprises cleaning the leader tissue 3 times with sterile 15% PBS, then soaking it in a penicillin / streptomycin mixed solution for 3 minutes, and then washing it 3 times with sterile 15% PBS.
[0013] Preferably, in step S2, adding 1 mg / mL type I collagenase to the girdle tissue for digestion and dispersion means adding 3 mL of 1 mg / mL type I collagenase for digestion and dispersion for every 10 girdle tissues.
[0014] Preferably, the digestion dispersion in step S2 is carried out at 37° C. and 250 r / min for 2 h.
[0015] Preferably, the culture medium in step S2 is composed of 15% fetal bovine serum, 1% penicillin / streptomycin mixture, and the remainder is high-glucose DMEM culture medium without phenol red, calculated by volume fraction.
[0016] Preferably, the conditions for static primary culture in step S2 are 5% CO2, 37°C, and saturated humidity.
[0017] Preferably, the point digestion in step S3 is to first add 1 drop of trypsin for digestion for 3 minutes, and then add 1 mL of trypsin for complete dispersion digestion for 3 minutes. The second object of the present invention is to provide gubernaculum testis mesenchymal stem cells prepared by the method.
[0018] The third object of the present invention is to provide the use of the gubernaculum testis mesenchymal stem cells in inducing differentiation of adipocytes, osteocytes and chondrocytes.
[0019] The second object of the present invention is to provide the use of the gubernaculum testis mesenchymal stem cells in the preparation of products for treating cryptorchidism or hormone regulation.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] (1) Fast speed: The TG-MSCs cultured in the present invention have a faster growth and proliferation rate than umbilical cord-derived MSCs. 0.2 g of umbilical cord Wharton's jelly tissue is cultured and subcultured under the same conditions and with the same operation. Based on the second generation cells with a fusion rate of 80% in the same volume of culture dish, the umbilical cord needs to be cultured for 26 days, while the testicular gubernaculum tissue only needs to be cultured for 20 days.
[0022] (2) High yield: Mouse gubernaculum tissue is small in size and light in weight. Each gubernaculum tissue weighs less than 1 μg. Ten gubernaculum tissues were extracted for cell culture and cell counting was performed at the third generation. The cell amount obtained at the third generation was 27 million cells, and the cell amount obtained at the fifth generation was 243 million cells, which is equivalent to 2.43 billion cells per milligram of gubernaculum tissue. The fifth generation of mesenchymal stem cells is usually selected for clinical treatment. Umbilical cord-derived MSCs only produce 1.645 billion third-generation cells and 14.805 billion fifth-generation cells per gram of Wharton's jelly; the yield of mesenchymal stem cells from the gubernaculum testis is much higher than that of umbilical cord mesenchymal stem cells.
[0023] (3) High purity: Flow cytometry was used to detect the expression of MSCs phenotype CD71 / CD90 / CD44 / CD34 / CD45. The test results showed that GT-MSCs had the MSCs phenotype and met the standards of the International Society for Cellular Therapy (ISCT).
[0024] (4) Multidirectional differentiation potential: Immunofluorescence technology was used to detect the mesoderm marker PDGFR-α / NKX2.5, and osteogenic, adipogenic, and chondrogenic differentiation were induced successfully, indicating that GT-MSCs can express multidirectional differentiation-related genes and have multidirectional differentiation potential, which meets the standards of the International Society for Cellular Therapy (ISCT).
[0025] The method of the present invention comprises the steps of collecting testicular gubernaculum tissue, digesting gubernaculum tissue, enriching and purifying gubernaculum cells, etc. The present invention partially digests tissue with collagenase to enrich gubernaculum cells, effectively screens out fibroblasts by a transfer method, and then digests cell colonies with trypsin in a dot-like manner to purify mesenchymal stem cells and amplify them in large quantities, and finally culture them to the third generation to establish a mesenchymal stem cell bank. In the early stage, an attempt was made to digest for a long time with trypsin, but the number of mesenchymal stem cells obtained by digestion was not as large as that obtained by short-time digestion; an attempt was also made to completely digest the tissue mass with trypsin and then pass it on, but the mesenchymal stem cells obtained were not as pure as the mesenchymal stem cells obtained by dot-like digestion.
[0026] The culture method of the present invention is fast, has a high yield, and has a simple source of raw materials. The mesenchymal stem cells obtained by culture are of high purity, have multidirectional differentiation potential and reproductive regulation function, and can express genes related to reproductive regulation. They can be used to study the disease mechanism and related treatment of cryptorchidism in children. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 The morphology of the second-generation GT-MSCs under a phase contrast microscope in Example 1 is shown. The cells are long spindle-shaped, have antennae, and are adherent cells. The scale bar is 250 μm.
[0028] Figure 2 The cell proliferation curve is obtained by using the CCK-8 method to measure the OD value of the GT-MSCs cells grown for 0-7 days in the third generation logarithmic growth phase in Example 1.
[0029] Figure 3 This is a statistical histogram based on the flow cytometry single peak diagram of the GT-MSCs marker differentiation cluster CD71, CD90 and CD44 positive cells and CD45, CD34 negative cells in Example 1.
[0030] Figure 4This is a single peak graph of the flow cytometry of the positive cells of the GT-MSCs marker differentiation cluster CD71, CD90 and CD44 and the negative cells of CD45 and CD34 in Example 1.
[0031] Figure 5 Immunofluorescence staining of TG-MSCs expressing mesodermal markers NKX2.5 and PDGFR-α.
[0032] Figure 6 These are the results of staining after the multidirectional differentiation experiment of GT-MSCs in Example 1; A is the result of Alizarin Red staining after osteogenic differentiation, B is the result of Oil Red O staining after adipogenic differentiation, and C is the result of Alcian Blue staining after chondrogenic differentiation.
[0033] Figure 7 This is the nucleic acid gel electrophoresis diagram of the G protein-coupled receptor gene RXFP2 (the receptor for INSL3, the main product of Leydig cells). The groups were normal control group (NC), solvent control group (DM) and drug-treated experimental group (a cryptorchid mouse model was constructed and treated with diethylstilbestrol (DES) at concentrations of 0.1μg / kg·d, 1μg / kg·d, 10μg / kg·d, and 100μg / kg·d (marked as 0.1μg, 1μg, 10μg, and 100μg on the figure, respectively). β-actin is the internal reference gene.
[0034] Figure 8 Statistical graphs of the relative expression levels of Nanog and Oct4 proteins in GT-MSCs cells in the normal control group (NC), solvent control group (solvent DMSO, marked DM on the figure), chloroquine (CQ, autophagy blocker) treated for 4 hours (marked CQ on the figure), DES treated for 24 hours (marked DES24H on the figure), and DES+CQ treated for 24 hours (marked D+C 24H on the figure); A is the Western Blot result graph, B is the Nanog protein level bar graph, and C is the Oct4 protein level bar graph; the results in B and C are mean ± SD, n = 3, *, ** indicate significant differences between the treatment group and NC at the levels of P < 0.05 and P < 0.01, respectively.
[0035] Fig. 9 This is the protein standard curve prepared in Example 6.
[0036] Fig.10Figure 2 is a Western blot SDS-PAGE gel electrophoresis of G protein-coupled receptor RXFP2. A: The experimental protein was taken from mouse gubernaculum testis tissue, NC was the control group without any treatment, DM was the solvent control group (DMSO treatment), and the mice in the experimental group were treated with DES (DES was injected subcutaneously into the mother mice, and the gubernaculum testis tissue of the young mice was extracted). The concentrations of DES were 0.1μg / kg·d (marked as DES 0.1 on the figure), 1μg / kg·d (marked as DES1 on the figure), 10μg / kg·d (marked as DES10 on the figure), and 100μg / kg·d (marked as DES100 on the figure), respectively, of which GAPDH was the internal reference protein; B: The protein was taken from the second-generation GT-MSCs, NC was the control group without any treatment, DM was the solvent control group, and the experimental group was treated with second-generation GT-MSCs with DES at concentrations of 0.01μg / kg·d (marked as DES 0.01), 0.1μg / kg·d (marked as DES 0.1 on the figure), 1μg / kg·d (marked as DES1 on the figure), 10μg / kg·d (marked as DES10 on the figure), GAPDH is the internal reference protein; C and D are statistical analysis graphs of the relative contents of RXFP2 / GAPDH proteins in A and B, respectively (the results are mean ± SD, n = 3, *** indicates that different concentrations of DES treatment are significantly different from NC at the level of P < 0.001).
[0037] Fig.11 Western Blot was used to detect the protein levels of LC3 (LC3 is an autophagosome marker) and P62 (autophagic degradation substrate marker) in GT-MSCs cells treated with DES for 12h (DES12H), 24h (DES 24H), 48h (DES 48H) and DES+CQ combined treatment for 12h (D+C 12H), 24h (D+C 24H), 48h (D+C 48H), with GAPDH as the internal reference; A is the Western Blot detection result of LC3, B and C are statistical graphs of the relative expression level of LC3 protein, D is the Western Blot detection result of P62; E and F are statistical graphs of the relative expression level of P62 protein (mean ± SD, n = 3, **, *** indicate significant differences between the treatment group and NC at the levels of P < 0.01 and P < 0.001, respectively). DETAILED DESCRIPTION
[0038] The following examples are provided to further illustrate the present invention, rather than to limit the present invention.
[0039] The experimental animals were Kunming mice, 8-10 weeks old, free of mouse-specific pathogens, purchased and raised at Shantou University Medical College. All animals were well-nourished and had normal mental and neurological status. The Animal Experiment Ethics Committee of Shantou University Medical College approved the use of Kunming mice as experimental subjects (NO.SUMC 2018-064).
[0040] High-glucose DMEM medium without phenol red was purchased from Wuhan Punosai Biotechnology Co., Ltd. with the catalog number PM150316.
[0041] Example 1
[0042] A method for obtaining mesenchymal stem cells with multidirectional differentiation potential and reproductive regulation function from mouse gubernaculum testis culture, the specific steps are as follows.
[0043] (1) Male mice born 0-3 days old were killed by soaking in 75% ethanol-water solution for 15 minutes. The mice were then placed in iodine solution and soaked for 15 minutes. They were then disinfected by soaking in 75% ethanol-water solution for 5 minutes in a clean bench. The iodine attached to the surface of the mice was removed and the disinfected mice were washed clean by soaking in saline.
[0044] (2) Place the mouse in a sterile dish covered with sterile gauze for dissection. Cut the skin of the lower abdomen horizontally and then longitudinally to the anus. Spread the skin to expose the bladder and the testicles on both sides of the bladder. Gently lift the testicle with microtweezers and cut off the testicle, epididymis and gubernaculum together.
[0045] (3) Place the removed tissue in a drop of sterile 15% phosphate buffered saline (PBS, purchased from Lonza), and wash the tissue fluid and blood with sterile 15% PBS, repeating 3 times until it is clean. Use microtweezers to separate the girdle tissue, place the separated girdle tissue in a drop of penicillin / streptomycin mixed solution (purchased from Lonza) and soak it for 3 minutes, then wash it 3 times with sterile 15% PBS.
[0046] (4) Place the collected fascia tissue in a 15-mL sterile centrifuge tube, add approximately 3 mL of type I collagenase (concentration of 1 mg / mL) (purchased from Worthington) according to the volume of the fascia tissue (add 3 mL of type I collagenase to 10 fascia tissues from 5 mice), and digest for 2 h in a constant temperature shaker at 37°C at 250 r / min to digest the fibrin around the fascia tissue, loosen the fascia tissue, and allow the stromal cells to crawl out of the tissue block.
[0047] (5) Add an equal volume of high-glucose DMEM medium without phenol red and containing 15% fetal bovine serum (FBS) (the composition is as follows by volume percentage: 15% fetal bovine serum, 1% penicillin / streptomycin mixture, and the remainder is high-glucose DMEM medium without phenol red) to terminate the digestion of type I collagenase, centrifuge at 1200 rpm for 5 min, discard the supernatant, and then add 5 mL of high-glucose DMEM medium without phenol red and containing 15% fetal bovine serum to fully resuspend the obtained mesenchymal stem cells and transfer them to a sterile culture bottle.
[0048] (6) Place the cells in a 5% CO2, 37°C saturated humidity incubator for static culture. Replace the culture medium after the cells have attached to the wall (approximately 3 days).
[0049] (7) Observe cell growth under an inverted microscope. Subculture when the cell fusion rate reaches about 80%. Use trypsin (Gibco, Life Technologies) to digest the cell colonies in a dotted manner and subculture them. Repeat the subculture until the third generation to establish a cell bank and obtain gubernaculum testis mesenchymal stem cells (GT-MSCs). The specific method of dotted digestion is: first add 1 drop of trypsin to the local area of the cell clumps for digestion for 3 minutes, then add 1 mL of trypsin to completely disperse and digest for 3 minutes.
[0050] Extract 10 girdle tissues to obtain a dish (25cm 2 ) primary cells, with a cell count of 1 million. After 20 days of culture, the cell fusion rate reached 80%, and subculture was possible. The morphology and cell size of the second generation GT-MSCs are shown in Figure 2. Figure 1 As shown. Figure 1 It can be seen that GT-MSCs are typical fibroblast-like, with an elongated, adherent and spindle-shaped morphology.
[0051] Example 2
[0052] In this example, the growth rate of the cells obtained in Example 1 was studied, and the growth curve of the cells was detected by CCK-8 (Cell Counting Kit-8). The specific operation steps and results are as follows.
[0053] (1) Collect cells (third generation) grown for 2-3 days (logarithmic growth phase) and prepare single-cell suspension. After counting the cells, adjust the concentration of the single-cell suspension. Add 100 μL of the single-cell suspension to each well of a 96-well plate, and adjust the density of the cells to be tested to 4000-5000 cells / well.
[0054] (2) Cultivate with cell culture medium, which is high-glucose DMEM medium without phenol red (containing 15% FBS and 1% penicillin / streptomycin mixed solution), place the 96-well plate in a 5% CO2, 37°C incubator and culture for 1-7 days. Detect once at the same time point every day.
[0055] (3) The cell culture medium was discarded, and the cells were washed once with PBS to remove floating dead cells. 100 μL of fresh high-glucose DMEM medium without phenol red and 10 μL of CCK-8 solution (Absin, abs50003) were added to each well.
[0056] (4) After incubating in the cell culture incubator for 1 hour, use an ELISA reader to measure the absorbance (OD value) at a wavelength of 450 nm. Repeat the test three times and take the average value. Record the test results every day.
[0057] (5) Use time as the horizontal axis and absorbance (OD value) as the vertical axis to draw a cell proliferation curve. The exponential growth phase of the cells can be seen from the cell proliferation curve.
[0058] Depend on Figure 2 It can be seen that GT-MSCs grow to the logarithmic phase in 2-4 days. Ten leader tissues were cultured according to the above culture method. After subculture to the third generation of cells, the cell count was performed and the cell count was 2.72×10 7 indivual.
[0059] Example 3
[0060] In this example, the cell phenotype of the mesenchymal stem cells obtained in Example 1 was identified by flow cytometry and immunofluorescence. The specific operation steps and results are as follows.
[0061] 1. Flow cytometry
[0062] (1) Preparation of materials: Take out the antibodies FITC anti-mouse CD90.2, FITC anti-mouse CD71, APC anti-mouse CD34, APC anti-mouse CD45 (Biolegend), and fetal bovine serum FBS (purchased from Pronocell), and place them on ice away from light;
[0063] (2) The third generation GT-MSCs cells in the logarithmic growth phase were taken and digested in the same way as before. The cells were gently blown to avoid cell breakage. The digested cells were centrifuged at 1500 rpm for 5 min to collect the cells;
[0064] (3) Prepare 1.5 mL EP tubes, group them according to the antibodies to be tested, mark the antibodies, and keep a blank control tube;
[0065] (4) Discard the supernatant of the collected cells, add 1 mL of 4°C pre-cooled PBS (Biyuntian), and resuspend the cells into a single cell suspension;
[0066] (5) Pipette 1 mL of the cell suspension into a 1.5 mL EP tube, wash the cells twice with 1 mL of pre-cooled PBS, and pre-cool the centrifuge at 4°C; then centrifuge at 4500 rpm for 5 min to collect the cells;
[0067] (6) Prepare blocking solution: Prepare blocking solution according to the volume ratio of goat serum:PBS=1:9, and add 100 μL of blocking solution to each tube;
[0068] (7) Discard PBS, add the prepared blocking solution to the cells, resuspend into a cell suspension, add 100 μL to each EP tube, and incubate for 10 min;
[0069] (8) After incubation, antibodies (FITC anti-mouse CD71 (2.5 μL / 100 μL), APC anti-mouse CD34 (2.5 μL / 100 μL), APC anti-mouse CD45 (2.5 μL / 100 μL), or FITC anti-mouse CD90.2 (4 μL / 100 μL)) were added to each tube in proportion and incubated on ice in the dark for 15 min;
[0070] (9) Place the incubated cells in a 4°C precooled centrifuge, centrifuge at 4500 rpm for 5 min, and discard the supernatant;
[0071] (10) Add 500 μL PBS to each tube, resuspend the cell suspension, and filter it with a cell strainer;
[0072] (11) Perform the test in a dark environment.
[0073] Depend on Figure 3 , Figure 4 It can be seen that the cell phenotype was established by flow cytometry using a set of surface markers, showing positive cells for the MSCs marker cluster of differentiation CD71, CD90 and CD44 and negative cells for CD45 and CD34, with the expression of CD90 and CD44 as high as 97.7% and 99.1%, CD44- was 0.302%, and CD34- was 2.06%. This shows that GT-MSCs do have the phenotype of MSCs and meet the standards of the International Society for Cellular Therapy (ISCT).
[0074] 2. Immunofluorescence staining
[0075] Clean bench disinfection, prepare items and place them on the clean bench, disinfect with ultraviolet light for 30 minutes, and take out the reagents and place them at room temperature to rewarm.
[0076] (1) Preparation of cell slides: Take a 24-well culture plate, add a small amount of high-glucose DMEM medium without phenol red to the bottom of the culture plate, evenly spread the bottom of the plate, and place the cell slide at the bottom of the 24-well culture plate until the slide is tightly attached to the bottom of the plate;
[0077] (2) Take the second generation (P2) cells in the exponential growth phase, subculture them on a 24-well plate at an appropriate density, and grow them on a slide. The cell density should not be too high, and it is best if the cells do not grow together or adhere to each other, so that the cell fluorescence can be clearly and completely photographed.
[0078] (3) When the cells adhere to the wall and grow to about 40% fusion, discard the high-glucose DMEM medium without phenol red; if drug treatment is required, the cell density can be increased to 30%, and DES can be added for 24 hours before drug treatment;
[0079] (4) Discard the culture medium and slowly pipette with pre-cooled PBS to wash away the suspended and detached dead cells. Repeat this three times, 3 min each time.
[0080] (5) Add 200 μL of 4% paraformaldehyde to each well and fix the cells for 15 min;
[0081] (6) Wash again with PBS, three times, 5 min each time;
[0082] (7) At room temperature, add 200 μL of 0.5% Triton X-100 aqueous solution to each well of cells to penetrate the cell membrane so that the primary antibody binding solution can easily pass through the cell membrane and enter the cytoplasm;
[0083] (8) Repeat step (5);
[0084] (9) Add 200 μL of 10% goat serum to each well of cells for blocking and incubate at room temperature for 45 min-60 min;
[0085] (10) Preparation of primary antibodies: dilute the primary antibodies according to the instructions: PDGFR-α (purchased from Abcam (USA), ab97355, dilution ratio is 1:200), NKX2.5 (purchased from CST (USA), 3868, dilution ratio is 1:200);
[0086] (11) Discard the serum blocking solution and add 200 μL of primary antibody to each well, and incubate in a 4°C refrigerator overnight;
[0087] (12) Discard the primary antibody and wash with PBS for 10 min, three times;
[0088] (13) Add secondary antibody (Alexa Fluor 488-labeled goat anti-rabbit IgG (H+L) (1:500) and incubate at room temperature for 60 min. Keep the cells away from light.
[0089] (14) Repeat step (5);
[0090] (15) Add anti-fluorescence quencher containing DAPI (1 mg / mL) dropwise to cover the entire slide;
[0091] (16) Use tweezers to gently pry up the slide, turn it upside down on the slide, and seal it with transparent nail polish to fix it on the slide to prevent it from moving;
[0092] (17) Place the prepared slide under a confocal microscope and observe and photograph it, taking care to avoid light.
[0093] Depend on Figure 5 It can be seen that TG-MSCs express mesoderm markers NKX2.5 and PDGFR-α, which further illustrates that TG-MSCs have the potential for multidirectional differentiation.
[0094] Example 4
[0095] In this example, the pluripotency of the gubernaculum testis mesenchymal stem cells obtained in Example 1 was studied by inducing multidirectional differentiation. The specific steps and results are as follows.
[0096] 1.1 Adipogenic differentiation
[0097] (1) 400,000 third-generation cells were inoculated onto a six-well plate according to the plating method to ensure uniform distribution of the cells. After the cells were cultured for 2 days and the fusion density reached 80%-90%, the high-glucose DMEM medium without phenol red was discarded, the cells were rinsed with PBS three times, the PBS was discarded, and 2 mL of adipogenic differentiation medium A (purchased from OriCell, MUXMX-90031 / 200 mL) was added;
[0098] (2) After continuous culture for 3 days, remove the old medium with a pipette and add 2 mL of adipogenic differentiation medium B (purchased from OriCell, MUXMX-90031 / 200 mL);
[0099] (3) After culturing for 24 h, discard the adipogenic differentiation medium B and add 2 mL of adipogenic differentiation medium A again, and continue culturing for 3 days;
[0100] (4) After using adipogenic differentiation medium A and adipogenic differentiation medium B alternately for 3-5 times in the above time sequence, continue culturing with adipogenic differentiation medium B for 4-7 days, changing the medium every 2-3 days;
[0101] (5) After 3 weeks of induction culture, when lipid droplets become sufficiently round and large (lipid droplet volume is greater than 40% of the cell volume), Oil Red O staining is performed for detection.
[0102] 1.2 Oil Red O staining method
[0103] (1) Take out the induced differentiated cells and rinse them with PBS three times, 5 min each time;
[0104] (2) Add 200 μL of 4% paraformaldehyde solution and fix in a 4°C refrigerator for 30 min;
[0105] (3) Discard the 4% paraformaldehyde solution and rinse again with PBS three times, each time for 5 min;
[0106] (4) Discard PBS, add 1 mL of Oil Red O working solution (purchased from OriCell, OILR-10001) (mix well according to the volume ratio of storage solution: distilled water = 3:2, and filter with neutral filter paper), and incubate at room temperature for 30 min;
[0107] (5) Discard the Oil Red O staining solution and rinse with PBS three times, 5 min each time;
[0108] (6) Rinse with distilled water, observe and photograph under an inverted phase contrast microscope.
[0109] 2.1 Chondrogenic differentiation
[0110] (1) Select OriCell mouse bone marrow mesenchymal stem cell chondrogenic differentiation kit (purchased from OriCell, MUXMX-90041 / 200mL) and add Add 2 mL of mouse bone marrow mesenchymal stem cell chondrogenic differentiation supplement I (hereinafter referred to as supplement I) Prepare the premix in 97 mL of cell basal culture medium (hereinafter referred to as basal culture medium);
[0111] (2) Take 400,000 third-generation cells, digest them, centrifuge them, transfer them into a 15 mL centrifuge tube, and centrifuge them at 800 rpm for 5 min;
[0112] (3) Discard the supernatant, add 0.5 mL of premixed solution, resuspend the pellet obtained by centrifugation in the previous step to wash the cells, and centrifuge at 560 rpm for 5 min at room temperature;
[0113] (4) Repeat step (3) and wash the cells again;
[0114] (5) Addition of Supplement II for Chondrogenic Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells (hereinafter referred to as Supplement II): according to the ratio (10 μL of Supplement II is added to 1 mL of premix), pipette the required dose of Supplement II for the experiment, add it to the corresponding volume of premix to prepare complete medium for chondrogenic differentiation, and mix by gentle pipetting;
[0115] (6) resuspending the precipitate obtained in step (4) with 0.5 mL of complete chondrogenic induction medium and centrifuging again at 560 rpm for 5 min at room temperature;
[0116] (7) Loosen the cap of the centrifuge tube to facilitate gas exchange and place it in an incubator at 37°C and 5% CO2 (do not shake the centrifuge tube within 24 hours).
[0117] (8) Starting from the time of inoculation, replace the cells with fresh complete chondrogenic differentiation medium every 2-3 days, with about 0.5 mL of complete chondrogenic differentiation medium per tube. Be careful not to aspirate the chondrocytes.
[0118] (9) After replacing the culture medium with complete chondrogenic induction medium, gently tap the bottom of the centrifuge tube to detach the chondrocytes from the bottom of the tube and suspend them in the liquid. Slightly loosen the cap of the centrifuge tube and place it in an incubator at 37°C and 5% CO2 to continue induction culture.
[0119] (10) Generally, after 21-28 days of induction, the chondrocytes can be fixed with formalin, embedded in paraffin, and sectioned, and finally stained with Alcian blue.
[0120] 2.2 Alcian blue staining experiment
[0121] 2.2.1 Preparation of paraffin sections
[0122] 2.2.1.1 Fixation: The induced chondrocytes were washed with PBS and then immersed in 4% paraformaldehyde solution (purchased from Bio-Tech, P0099) for fixation for more than 30 minutes;
[0123] 2.2.1.2 Dehydration: The fixed cartilage balls were dehydrated with gradient concentrations of alcohol in the following manner: 50% alcohol - 70% alcohol - 80% alcohol - 95% alcohol - anhydrous alcohol; each stage lasted 30 minutes;
[0124] 2.2.1.3 Transparency: Since alcohol and paraffin are incompatible, they need to be transitioned through xylene after dehydration. The method is as follows:
[0125] (1) Mix xylene and anhydrous alcohol in a volume ratio of 1:1 and soak the cartilage balls in it for 2 h;
[0126] (2) Soak the cartilage balls in pure xylene for 1.5 h;
[0127] (3) Replace with new xylene and continue soaking for 1 hour;
[0128] 2.2.1.4 Wax dipping: Wax dipping is necessary to remove the transparent agent in the cartilage ball and allow the paraffin to penetrate into the interior for embedding:
[0129] (1) Xylene and paraffin were mixed in a volume ratio of 1:1, the chondrocytes were immersed in the mixture, and then placed in a 40°C oven for 40 min;
[0130] (2) soaking the cartilage balls treated in step (2) in pure paraffin and placing them in a 55° C. oven for 30 min;
[0131] 2.2.1.5 Embedding: Take out the cartilage ball, place it in a mold, pour in paraffin, let it stand and cool, wait until the paraffin is fully cooled and formed, take it out, and trim the wax block.
[0132] 2.2.1.6 Sectioning: Serial sections, each section is 3 μm thick;
[0133] 2.2.1.7 Adhesion: Adhere the cartilage ball slices to the glass slide with adhesive and dry them in an oven at 35℃;
[0134] 2.2.1.8 Dewaxing:
[0135] (1) Soak the slices in xylene for 15 min, then replace with new xylene and soak for 10 min;
[0136] (2) Mix xylene and anhydrous alcohol in a volume ratio of 1:1 and soak the slices for 10 min;
[0137] (3) Soak the slices in 95%, 85%, 70%, and 50% alcohol for 10 min, and let them dry.
[0138] 2.2.2 Alcian blue staining
[0139] (1) Add Alcian blue staining solution to the paraffin section to completely cover the specimen and stain in a 37°C water bath for 1 h.
[0140] (2) Rinse the slides with tap water for 5 minutes;
[0141] (3) Dehydrate the sections with gradient alcohol (50% alcohol-70% alcohol-80% alcohol-95% alcohol-absolute ethanol), dehydrate for 5 min at each concentration, then transparentize with xylene and air-dry in a fume hood;
[0142] (4) After sealing with neutral gum, observe and photograph under an inverted microscope.
[0143] 3.1 Osteogenic differentiation
[0144] (1) Prepare complete osteoinduction differentiation medium (purchased from OriCell, MUXMX-90021 / 200mL): Add all the high-grade fetal bovine serum (20 mL) and osteogenic differentiation supplement (3 mL) in the mouse bone marrow mesenchymal stem cell osteogenic differentiation kit to the in basal medium (177 mL);
[0145] (2) Take 400,000 second-generation GT-MSCs cells and inoculate them onto a six-well plate according to the plating method to evenly distribute the cells. After the cells adhere to the wall for 2 days and the fusion density reaches 80%-90%, discard the ordinary culture medium (high-glucose DMEM culture medium without phenol red), wash with PBS 3 times, add 2 mL of osteogenic differentiation complete culture medium for induction, change the medium (osteogenic differentiation complete culture medium) once every three days, and after 4 weeks of induction, observe the morphological changes and growth of the cells, and stain with Alizarin Red after calcium nodules appear. To prevent osteoblasts from falling off, it is recommended that after a large number of calcium nodules appear during the osteogenesis process, the medium should be changed to half the amount of medium (osteogenic differentiation complete culture medium) every two days.
[0146] 3.2 Alizarin red staining
[0147] (1) After the osteogenic differentiation was completed, the differentiated cells were removed, the osteogenic differentiation complete medium was discarded, and the cells were rinsed with PBS three times, each time for 5 min;
[0148] (2) Add 200 μL of 4% paraformaldehyde solution and fix in a 4°C refrigerator for 30 min;
[0149] (3) Discard the 4% paraformaldehyde solution and rinse again with PBS three times, 5 min each time;
[0150] (4) Add 1 mL of Alizarin Red dye (purchased from OriCell, ALIR-10001) to each well and stain for 3-5 minutes;
[0151] (5) Discard the alizarin red dye solution and repeat step (3);
[0152] (6) Observe the osteogenic differentiation staining results in the culture plate under an inverted phase contrast microscope and take photos to record.
[0153] Depend on Figure 6 It can be seen that after 3 weeks of adipogenic induction, a large number of lipid droplets were visible in the cytoplasm, and about 85% of the cells were positive after Oil Red O staining ( Figure 6 B); After 4 weeks of osteogenic differentiation, the results of alizarin red staining showed that the cells showed a large amount of calcium salt deposition, and about 80% of the cells were positive ( Figure 6A); in chondrogenic differentiation, after 4 weeks of induction, immunohistochemical staining with Alcian blue showed that there were clustered chondrocytes in the induced group ( Figure 6 C), the above results show that TG-MSCs have the potential for multi-directional differentiation into adipogenesis, osteoblastogenesis, and chondrogenesis, and the differentiation direction is mesoderm, which indicates that TG-MSCs have the potential to induce differentiation into mesoderm.
[0154] Example 5
[0155] In this example, the hormone regulation function of Leydig cells was identified by qualitative analysis of the G protein coupled receptor gene RXFP2 (receptor of the main product INSL3 of Leydig cells) using nucleic acid gel electrophoresis technology. The specific operation steps and results are as follows.
[0156] (1) Preparation of electrophoresis buffer
[0157] The nucleic acid electrophoresis buffer is divided into TAE buffer, 50×TAE buffer is prepared, and it is diluted into 1×TAE buffer for use. The preparation of 50×TAE buffer is shown in Table 1.
[0158] Table 1 50×TAE Buffer Preparation (needs to be diluted 50 times before use)
[0159] Reagents Weighing value method Tris (Tromethamine) 242g Place in a 1L beaker, add about 600mL of deionized water, and stir thoroughly; <![CDATA[Na2EDTA·2H2O]]> 37.2g <![CDATA[CH3COOH (glacial acetic acid)]]> 57.1mL After full dissolution, adjust the pH to 8.3 with NaOH and add deionized water to make up to 1L.
[0160] (2) Preparation of agarose gel
[0161] Rinse the gel-making mold and comb with distilled water, place them on the gel-making plate, seal the edge of the mold, set up the comb, prepare 1% agarose gel (100mL 1×TAE Buffer + 1g agarose), heat to dissolve, add 10μL YeaGreen nucleic acid dye (10000×, purchased from Yisheng Biotechnology, 10204ES), mix well, pour into the mold, and wait for cooling;
[0162] (3) After 30-45 minutes at room temperature, the gel is completely solidified. Carefully remove the comb and place the gel in the electrophoresis tank.
[0163] (4) Pour electrophoresis buffer into the electrophoresis tank. The amount should be enough to cover the gel surface by 1 mm. If there are bubbles in the sample well, try to remove them.
[0164] (5) Add 10× volume of loading buffer (purchased from Yisheng Biotechnology, 10213ES) to the DNA sample, mix well, and then use a gun to slowly add the sample mixture into the submerged gel loading well;
[0165] (6) Turn on the power supply, red is the positive pole, black is the negative pole, and remember that the DNA sample moves from the negative pole to the positive pole (the end close to the sample well is negative). Generally, the voltage is 60-100V, and the electrophoresis is 20-40 minutes;
[0166] (7) Determine whether to terminate electrophoresis based on the position of the indicator;
[0167] (8) After electrophoresis is completed, turn off the power supply, observe the electrophoresis band and its position on the gel imager, and compare the size of the amplified product with the nucleic acid molecular weight standard marker.
[0168] Figure 7 The results showed that the normal control group, solvent control group and different drug-administered experimental groups all expressed RXFP2 positive, and GT-MSCs had hormone regulation function.
[0169] Example 6
[0170] In this example, the hormone regulation function of Leydig cells was identified by qualitative analysis of the G protein-coupled receptor gene RXFP2 (receptor of the main product INSL3 of Leydig cells) of GMSCs by Western Blot. The specific operation steps and results are as follows.
[0171] 1. Cell protein extraction and concentration determination
[0172] 1.1 Total cell protein extraction
[0173] (1) Plate the cells in a 60 mm culture dish and extract the cell protein after the cells are treated with drugs;
[0174] (2) Preparation before the experiment: RIPA lysis buffer (purchased from Panera, AAPR51-100) and PMSF (100 mM, purchased from Biotol, B14001) were placed on ice to dissolve and set aside for use. PBS was placed in a 4°C refrigerator for precooling. A 1.5 mL EP tube was prepared and placed on ice for use. The cell scraper was washed and dried in a drying oven for use.
[0175] (3) Prepare the cell lysis buffer working solution: according to the cell amount and cell volume (1mL / 1×10 7 Prepare the working solution (RIPA lysis buffer: PMSF = 100:1 by volume), shake and mix well, and place on ice for later use. Make sure to prepare and use immediately.
[0176] (5) Remove the cells, discard the high-glucose DMEM medium without phenol red in the culture dish, and gently wash them three times with PBS to wash away the fetal bovine serum in the culture medium to avoid the influence of protease inhibitors;
[0177] (4) Add an appropriate amount of lysis buffer to each dish of cells (add 80 μL of cell lysis buffer to each dish with a diameter of 60 mm), quickly scrape the cells at the bottom of the dish with a cell scraper, and try to scrape the cells cleanly and thoroughly. Then transfer the lysis buffer containing cell fragments to a 1.5 mL EP tube and lyse them on ice for 30 minutes. Note that the cell scraper should be changed between different cells. This step and the entire process should be performed on ice to avoid protein degradation.
[0178] (5) Ultrasonication of each cell lysate was performed 4 times with a homogenizer and each time lasting 5 seconds, with an interval of 3 seconds;
[0179] (6) Precool the centrifuge to 4°C, place the 1.5 mL EP tube in the centrifuge and balance it, and centrifuge at 4°C and 13,500 rpm for 20 min;
[0180] (7) After centrifugation, take the supernatant and total cell protein and dispense them into 1.5 mL EP tubes. At the same time, dispense 6 μL for protein concentration determination. Then add 5× loading buffer at a ratio of 5× loading buffer: protein = 1:4. After mixing, place the EP tube on a 100°C dry constant temperature heater for 10 min. After cooling on ice, mark the group and store it in a -20°C refrigerator after the extraction date.
[0181] 1.2 Protein concentration determination
[0182] (1) Preparation before the experiment: 1.5 mL EP tube, PBS, BSA standard protein (from BCA kit, purchased from Panera, AAPR161-30);
[0183] (2) Prepare 0.5 μg / mL BSA protein standard sample using protein standard preparation solution for preparing a standard curve;
[0184] (3) Prepare BCA working solution: add 200 μL per well and prepare an appropriate amount of BCA working solution in the ratio of reagent A: reagent B = 50:1, and mix thoroughly;
[0185] (4) Add the standard substances to a 96-well plate in the order shown in Table 2. Note that three replicate wells should be set up to obtain the average value and set a concentration gradient to prepare a protein standard curve.
[0186] Table 2 Protein standard curve
[0187] Serial number 1 2 3 4 5 6 7 8 Standard concentration (μg / mL) 0 0.025 0.05 0.1 0.2 0.3 0.5 0.5 PBS (μL) 20 19 18 16 12 8 4 0 Diluted standard (μL) 0 1 2 4 8 12 18 20
[0188] (5) Dilute the protein sample to be tested 10 times with PBS, i.e., add 18 μL PBS and 2 μL protein sample to each well of a 96-well plate, and set the average of 3 replicate wells for each sample to reduce the error;
[0189] (6) Add 200 μL of BCA working solution to each well, cover the plate, and place it in a 37°C constant temperature oscillator and shake gently for 30 min. Avoid bubbles that may affect the results during the loading process.
[0190] (7) Take out the 96-well plate and cool it to room temperature. Open the plate cover and place it on a microplate reader to measure the absorbance (OD) at a wavelength of 562 nm. Set the standard protein concentration as the horizontal axis (mg / mL) and the absorbance as the vertical axis, and draw a standard protein curve (such as Fig. 9 ), showing R 2 The linear equation corresponding to the straight line is 2 >0.995, proving that this model is credible, and substituting the measured absorbance of each sample into this formula to obtain the corresponding protein concentration, which is then divided by the dilution factor to obtain the protein concentration of the sample.
[0191] 2. Western Blot detection of target protein expression
[0192] 2.1 Preparation of polyacrylamide gel (SDS-PAGE)
[0193] (1) Clean the BIO-RAD glass plate and comb with distilled water in advance and place them in a drying oven to dry. Clamp the glass plate with a glue clamp, align the bottom, and clamp it on the glue rack. Use distilled water to check for leaks. After confirming that there is no leakage, use filter paper to distill water and absorb it dry before making glue;
[0194] (2) Preparation of concentrated gel and separation gel: Select separation gel and concentrated gel of appropriate concentration according to requirements, prepare reagents according to Table 3 and prepare separation gel and concentrated gel. Prepare separation gel first, and then prepare concentrated gel after separation gel solidifies. The solidification time of separation gel and separation gel is about 30 min.
[0195] Table 3 Preparation of SDS-PAGE separation gel and stacking gel
[0196]
[0197] (3) After the separation gel is prepared, mix it upside down, and first inject the mixed separation gel solution into the gap between the glass plates to a height of about 3 / 5-4 / 5 of the glass plate. Then seal it with 75% alcohol to isolate the air so that the separation gel can solidify quickly, and at the same time, exhaust air bubbles to keep the upper edge of the separation gel horizontal; after the separation gel solidifies, pour out the 75% alcohol and use filter paper to absorb it, being careful not to touch the separation gel, and then inject the concentrated gel until the glass plate is filled, and then quickly and evenly insert the comb. Be careful to avoid bubbles during the process, and insert the comb quickly to prevent the concentrated gel from solidifying prematurely;
[0198] (4) The concentrated gel will solidify after being refined for about 30 minutes at room temperature. Place the prepared gel plate in ddH2O storage solution to keep it moist and store it in a 4℃ refrigerator for later use. Be sure to use it within 1 week.
[0199] 3. Western Blot
[0200] (1) Take out the gel prepared within 1 week from the 4°C refrigerator, insert the gel plate correctly into the vertical electrophoresis tank, add enough electrophoresis solution to the tank to level the glass plate, and then slowly pull out the comb vertically upwards, taking care not to damage the sample wells;
[0201] (2) Sample loading: In this experiment, the same mass of protein solution was loaded, and the loading amount of each sample was 20 μg. The loading volume was converted according to the protein concentration measured by the BCA detection method. The corresponding protein samples and 5 μL prestained protein marker (purchased from Thermo Fisher Scientific) were added to the sample wells in sequence;
[0202] (3) Electrophoresis: Place the inner tank into the outer tank, add an appropriate amount of electrophoresis liquid to the outer tank so that the electrophoresis liquid covers the metal wire at the bottom of the inner tank, and then cover the electrophoresis tank cover. Connect the positive and negative poles of the power supply correctly, turn on the power supply, set the parameters to 60V constant voltage to run the concentrated gel, and when the pre-stained protein Marker bands are clearly separated, pressurize to 120V constant voltage to run the separation gel until the Marker bands corresponding to the molecular weight of the target protein are clear and separated enough, then turn off the power supply to the tube wall and end the electrophoresis;
[0203] (4) Electroporation:
[0204] a. Cutting the membrane: Cut the appropriate PVDF membrane according to the size of the gel, mark the left and right sides and the front and back sides, and soak it in methanol solution for 5 minutes to activate the PVDF membrane;
[0205] b. Gel cutting: Take out the glass plate and use a seesaw to open it. Referring to the position of the marker band, cut the required gel strip at the relative molecular weight position of the gel. The protein molecular weights measured in this experiment are shown in Table 4.
[0206] Table 4 Relative molecular weight of target protein
[0207] Protein to be detected Molecular weight (kDa) Anti-LC3 Rabbit mAb 14-16 Anti-P62 Rabbit mAb 60 Anti-Nanog Rabbit mAb 29-42 Anti-Oct4 Rabbit mAb 45 Anti-GAPDH Rabbit mAb 36 Anti-β-actin Rabbit mAb 42 Anti-RXFP2 Rabbit mAb 86
[0208] c. Prepare a "sandwich transfer clip": prepare a transfer tray, fill it with a sufficient amount of pre-prepared electrotransfer buffer, put the transfer clip, sponge pad, and filter paper into the tray to wet them in advance, and the electrotransfer buffer should cover these devices. Place the sponge pad and 3 layers of cut filter paper on the negative plate of the transfer clip in order, carefully transfer the cut gel to the filter paper, and then turn the PVDF membrane upside down on the gel, paying attention to the order of left and right, gently exhaust the air bubbles, and avoid touching the protein surface of the PVDF membrane with your hands, and then stick another layer of sponge pad and filter paper on the positive plate, press the positive plate only on the negative plate, and close the transfer clip tightly;
[0209] d. Electrotransfer: Place the transfer clip into the transfer tank, add sufficient electrotransfer buffer and ice, and cover the electrotransfer tank. Move the transfer tank to an ice box and cover it with ice cubes. Connect the power supply, adjust the parameters, and start the transfer. The transfer parameters for this experiment are 200mA constant current, and the electrotransfer time is about the molecular weight plus 30min.
[0210] e. Blocking: Prepare the blocking solution (5% skim milk) in advance before transferring and place it on a shaker to mix well, so as to avoid incomplete dissolution of skim milk powder affecting the subsequent luminescence background. After the electrotransfer, place the PVDF membrane in the blocking solution and slowly block it on a shaker at room temperature for 1 hour.
[0211] f. Primary antibody incubation: transfer the corresponding PVDF membrane to the corresponding primary antibody dilution solution according to the position of the marker band, and place it on a shaker at 4°C and shake slowly overnight. The incubation time should be greater than 8 hours;
[0212] g. Wash the PVDF membrane with TBST the next day, place it on a shaker at room temperature and quickly wash for 10 min, repeat 3 times;
[0213] h. Secondary antibody incubation: transfer the PVDF membrane to the pre-prepared secondary antibody dilution solution and incubate slowly on a shaker at room temperature for 1 hour;
[0214] i. Wash the PVDF membrane with TBST and wash it quickly on a shaker at room temperature for 10 min. Repeat 3 times to wash away the secondary antibody dilution solution.
[0215] j. Chemiluminescence: Prepare chemiluminescent solution according to the ratio of luminescent solution A:B=1:1, mix thoroughly, and use it immediately after preparation. Avoid light during operation. After the strip is evenly stained with the luminescent solution, place the PVDF membrane protein side up in the chemiluminescence instrument, open Image Lab 3.0.1 software, set the parameters and exposure time, and then perform luminescence;
[0216] k. Band analysis: Save and export the image, use Image Lab 3.0.1 software to compare the grayscale values of the tested proteins between different groups, use the grayscale value of the internal reference of the control group as a benchmark, adjust the internal reference of each group to get a ratio; compare the grayscale value of the target protein value of each sample with the ratio of the internal reference to get the relative grayscale value of each experimental group, and then use the target protein of the control group as a benchmark to get the relative multiple of the target protein expression of the remaining treatment groups. Each target protein was tested 3 times, and statistical analysis was performed using SPASS23 software.
[0217] In this example, living mother mice were subcutaneously injected with different concentrations of DES (the concentrations of DES were 0.1 μg / kg·d, 1 μg / kg·d, 10 μg / kg·d, and 100 μg / kg·d), and the group without any treatment was designated as the no-treatment control group (NC), and the group treated with a solvent was designated as the solvent control group (DM); after the mother mice gave birth to pups, the gubernaculum testis of the pups was extracted, and GT-MSCs were cultured for experiments.
[0218] like Fig.10 As shown in the data, RXFP2 protein level was downregulated with the increase of DES concentration in a dose-dependent manner, and the difference was statistically significant compared with the control group (NC) without any treatment, indicating that the hormonal regulation of DES-induced cryptorchidism in children was affected.
[0219] Example 7
[0220] In this example, the protein levels of Nanog and Oct4 (Nanog and Oct4 are regulatory factors necessary for mesenchymal stem cells to maintain stem cell self-renewal and pluripotency) in the second generation GT-MSCs of subculture were quantitatively analyzed by protein immunoblotting (Western Blot) to identify the pluripotency of Leydig cells and the effect of DES on the pluripotency of GT-MSCs. The specific implementation method is the same as that of Example 6.
[0221] In this example, GT-MSCs were subcultured for the second generation of cells. The group without any treatment was set as the no-treatment control group (NC), the group treated with solvent was set as the solvent control group (DM), the group treated with chloroquine for 4 h was set as the CQ group (CQ), the group treated with diethylstilbestrol for 24 h was set as DES24H, and the group treated with DES for 24 h and chloroquine for 1 h was set as D+C 24H.
[0222] like Figure 8 As shown, the experimental results indicate that the mechanism of DES-induced cryptorchidism in children is to inhibit the expression of Nanog and Oct4 proteins by blocking the autophagy flow, thereby affecting the multipotency of GT-MSCs cells.
[0223] Example 8
[0224] In this example, the protein levels of LC3 (LC3 is an autophagosome marker) and P62 (autophagy degradation substrate marker) in the second generation GT-MSCs of subculture were analyzed by protein immunoblotting (Western Blot) to explore the disease mechanism of DES-induced cryptorchidism in children, and the specific implementation method is the same as Example 6. The increase in the relative expression of LC3-II / LC3-I reflects the formation of autophagosomes and promotes the occurrence of autophagic flow. The group without any treatment was the control group without any treatment (NC), the group with solvent treatment was the solvent control group (DM), and the treatment group DES treatment 12h (DES12H), 24h (DES24H), 48h (DES 48H) and DES+CQ combined treatment 12h (D+C 12H), 24h (D+C24H), 48h (D+C 48H).
[0225] like Fig.11 As shown in the figure, the experimental results show that DES inhibits GT-MSCs autophagy; while chloroquine blocks the autophagic flow (i.e., blocks the degradation of LC3), causing LC3 accumulation, so CQ and DES work synergistically to inhibit cell autophagy. This further shows that DES-induced mouse cryptorchidism is involved in the autophagy process of GT-MSCs and inhibits cell autophagy.
Claims
1. A method for obtaining gubernaculum testis mesenchymal stem cells from mouse gubernaculum testis tissue culture, characterized in that: The steps include: S1. Isolate the gubernaculum tissue from newborn male mice aged 0-3 days and clean the gubernaculum tissue; S2. Add 1 mg / mL type I collagenase to the girdle tissue for digestion and dispersion, transfer to a culture bottle, add culture medium for static primary culture, and replace the culture medium when the primary culture reaches cell attachment; S3. When the fusion rate of adherent cells reaches 80%, the cell colonies are digested with trypsin in a dot-like manner and then subcultured. After subculture to the third generation, a cell bank is established to obtain gubernaculum testis mesenchymal stem cells.
2. The method according to claim 1, characterized in that The step S1 of cleaning the leader tissue comprises cleaning the leader tissue 3 times with sterile 15% PBS, then soaking it in a penicillin / streptomycin mixed solution for 3 minutes, and then washing it 3 times with sterile 15% PBS.
3. The method according to claim 1, characterized in that In the step S2, 1 mg / mL type I collagenase is added to the girdle tissue for digestion and dispersion, and 3 mL of 1 mg / mL type I collagenase is added for digestion and dispersion for every 10 girdle tissues.
4. The method according to claim 1, characterized in that: The digestion dispersion in step S2 is carried out at 37° C. and 250 r / min for 2 hours.
5. The method according to claim 1, characterized in that: The culture medium in step S2 is composed of 15% fetal bovine serum, 1% penicillin / streptomycin mixed solution, and the remainder is high-glucose DMEM culture medium without phenol red, calculated by volume fraction.
6. The method according to claim 1, characterized in that The conditions for static primary culture in step S2 are 5% CO2, 37°C, and saturated humidity.
7. The method according to claim 1, characterized in that The point digestion described in step S3 is to first add 1 drop of trypsin for digestion for 3 minutes, and then add 1 mL of trypsin enzyme for complete dispersion digestion for 3 minutes.
8. The gubernaculum testis mesenchymal stem cells prepared by the method according to any one of claims 1 to 7.
9. Use of the gubernaculum testis mesenchymal stem cells according to claim 8 in inducing differentiation into adipocytes, osteocytes and chondrocytes.
10. Use of the gubernaculum testis mesenchymal stem cells according to claim 8 in the preparation of products for treating cryptorchidism or hormone regulation.
